33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2150407
176282
2
Public Timelines
FAQ Receber premium

23 maio 2017 ano - Pembrolizumab Approved

Descrição:

FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.

Adicionado na linha do tempo:

15 nov 2018
0
0
357

Data:

23 maio 2017 ano
Agora
~ 8 years and 4 months ago